Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group.

Abu-Duhier FM, Goodeve AC, Wilson GA, Gari MA, Peake IR, Rees DC, Vandenberghe EA, Winship PR, Reilly JT.

Br J Haematol. 2000 Oct;111(1):190-5.

PMID:
11091200
2.

Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.

Andersson A, Johansson B, Lassen C, Mitelman F, Billström R, Fioretos T.

Eur J Haematol. 2004 May;72(5):307-13.

PMID:
15059064
3.

Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.

Steudel C, Wermke M, Schaich M, Schäkel U, Illmer T, Ehninger G, Thiede C.

Genes Chromosomes Cancer. 2003 Jul;37(3):237-51.

PMID:
12759922
4.

Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia.

Moreno I, Martín G, Bolufer P, Barragán E, Rueda E, Román J, Fernández P, León P, Mena A, Cervera J, Torres A, Sanz MA.

Haematologica. 2003 Jan;88(1):19-24.

5.

Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children.

Xu F, Taki T, Yang HW, Hanada R, Hongo T, Ohnishi H, Kobayashi M, Bessho F, Yanagisawa M, Hayashi Y.

Br J Haematol. 1999 Apr;105(1):155-62.

PMID:
10233379
6.

Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome.

Shih LY, Lin TL, Wang PN, Wu JH, Dunn P, Kuo MC, Huang CF.

Cancer. 2004 Sep 1;101(5):989-98.

7.

Risk assessment in patients with acute myeloid leukemia and a normal karyotype.

Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T.

Clin Cancer Res. 2005 Feb 15;11(4):1416-24. Erratum in: Clin Cancer Res. 2005 Aug 1;11(15):5659.

8.

Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia.

Liang DC, Shih LY, Hung IJ, Yang CP, Chen SH, Jaing TH, Liu HC, Chang WH.

Cancer. 2002 Jun 15;94(12):3292-8.

10.

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

Kiyoi H, Naoe T, Nakano Y, Yokota S, Minami S, Miyawaki S, Asou N, Kuriyama K, Jinnai I, Shimazaki C, Akiyama H, Saito K, Oh H, Motoji T, Omoto E, Saito H, Ohno R, Ueda R.

Blood. 1999 May 1;93(9):3074-80.

11.

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.

Meshinchi S, Woods WG, Stirewalt DL, Sweetser DA, Buckley JD, Tjoa TK, Bernstein ID, Radich JP.

Blood. 2001 Jan 1;97(1):89-94.

12.

Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.

Whitman SP, Archer KJ, Feng L, Baldus C, Becknell B, Carlson BD, Carroll AJ, Mrózek K, Vardiman JW, George SL, Kolitz JE, Larson RA, Bloomfield CD, Caligiuri MA.

Cancer Res. 2001 Oct 1;61(19):7233-9.

13.

[Prevalence and clinical significance of FLT3 internal tandem duplication mutation in acute leukemia].

Wang LH, Zhou CL, Zhang XW, Chen S, Wang M, Wang JX.

Zhonghua Xue Ye Xue Za Zhi. 2004 Jul;25(7):393-6. Chinese.

PMID:
15355689
14.

Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication.

Muñoz L, Aventín A, Villamor N, Juncà J, Acebedo G, Domingo A, Rozman M, Torres JP, Tormo M, Nomdedéu JF.

Haematologica. 2003 Jun;88(6):637-45.

15.

FLT3 mutations in myeloid sarcoma.

Ansari-Lari MA, Yang CF, Tinawi-Aljundi R, Cooper L, Long P, Allan RH, Borowitz MJ, Berg KD, Murphy KM.

Br J Haematol. 2004 Sep;126(6):785-91.

PMID:
15352981
16.

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

Fröhling S, Schlenk RF, Breitruck J, Benner A, Kreitmeier S, Tobis K, Döhner H, Döhner K; AML Study Group Ulm. Acute myeloid leukemia..

Blood. 2002 Dec 15;100(13):4372-80. Epub 2002 Aug 8.

17.

FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance.

Zwaan CM, Meshinchi S, Radich JP, Veerman AJ, Huismans DR, Munske L, Podleschny M, Hählen K, Pieters R, Zimmermann M, Reinhardt D, Harbott J, Creutzig U, Kaspers GJ, Griesinger F.

Blood. 2003 Oct 1;102(7):2387-94. Epub 2003 Jun 19.

18.

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

Thiede C, Steudel C, Mohr B, Schaich M, Schäkel U, Platzbecker U, Wermke M, Bornhäuser M, Ritter M, Neubauer A, Ehninger G, Illmer T.

Blood. 2002 Jun 15;99(12):4326-35.

19.

Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

Yamamoto Y, Kiyoi H, Nakano Y, Suzuki R, Kodera Y, Miyawaki S, Asou N, Kuriyama K, Yagasaki F, Shimazaki C, Akiyama H, Saito K, Nishimura M, Motoji T, Shinagawa K, Takeshita A, Saito H, Ueda R, Ohno R, Naoe T.

Blood. 2001 Apr 15;97(8):2434-9.

20.

Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia.

Kondo M, Horibe K, Takahashi Y, Matsumoto K, Fukuda M, Inaba J, Kato K, Kojima S, Matsuyama T.

Med Pediatr Oncol. 1999 Dec;33(6):525-9.

PMID:
10573574

Supplemental Content

Support Center